Searched for
HILLEMAN LABORATORIES
Aurobindo unit terminates pact with Singapore firm to develop pentavalent vaccineAurobindo Pharma has terminated a license agreement through its subsidiary Auro Vaccines with Hilleman Laboratories for developing a pentav...- Bharat Biotech launches oral cholera vaccine Hillchol after positive phase 3 trialBharat Biotech unveiled Hillchol, a new single-strain oral cholera vaccine, developed with Hilleman Laboratories. Addressing the high globa...
- Aurobindo Pharma shares jump 6% on reports of nod to launch cancer drug RevlimidOn Wednesday, Aurobindo Pharma's wholly owned subsidiary Auro Vaccines Private Limited informed about entering into a License Agreement wit...
- Hilleman Labs to partner future vaccine manufacturing hubUK Department for Health has granted GBP 10 million funding for the hub that will be managed by the Engineering and Physical Sciences Resea...
- Hilleman Laboratories receives Swedish grant for oral cholera vaccineThe World Health Organisation estimates that there are nearly every year there are roughly 1.3 to 4 million cases Cholera cases globally an...
- Hilleman Labs, NICED to develop Shigella VaccineThe two aim to complete the development of this vaccine by 2024, according to Hilleman Labs chief executive officer Davinder Gill.
- Hilleman Laboratories begins clinical trials of rotavirus vaccineHilleman Labs received approvals to conduct phase I and II clinical trials for the two vaccines in recent weeks from Directorate General of...
- Hilleman Lab scouts for partners to develop low cost vaccinesHilleman said it is looking to tie up with vaccine specialty companies and government agencies to fund a Rs 300 project for developing some...
- Hilleman Lab to invest Rs 300 crore to develop vaccines"We are spending around Rs 300 crore over the next 4-5 years to develop low-cost vaccines. We are developing vaccines to treat rotavirus, c...
- Hilleman Laboratories loses key executivesSome of the top executives, including the founding CEO, have moved on from Delhi-based vaccine research firm Hilleman Laboratories.
- Wellcome, Merck JV to make anti-diarrhoea vaccine for babiesAn Indian healthcare JV between Merck & Co and Wellcome Trust plans to develop heat stable oral rotavirus vaccine to prevent diarrhoea in b...
- Hilleman Lab to invest about Rs 650 cr to develop vaccinesAs per the company's estimates, it will take 2-4 years in research and development activities to come out with the new vaccine.
Load More
